Macleods Pharma USA, Inc. is recalling 1,315 bottles of Levothyroxine Sodium tablets (150 mcg) because the drug is subpotent, meaning it may not contain the full amount of active medication required. This recall affects the 1,000-count bottles distributed nationwide to wholesalers and retail pharmacies. No injuries or incidents have been reported to date regarding this recall.
The drug was found to be subpotent, which means patients taking this medication may not receive the intended dose of thyroid hormone. This could lead to uncontrolled symptoms of hypothyroidism, such as fatigue, weight gain, and cold intolerance.
You have 2 options:
Manufactured by Macleods Pharmaceuticals Ltd., India
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.